Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms - Lee, Yi-Ju; Lee, Ming-Yung; Ruan, Alexandra; Chen, Chi-Kuan; Liu, Hao-Ping; Wang, Chau-Jong; Chao, Wan-Ru; Han, Chih-Ping (Oncotarget, 2016)
Keywords: Adenoma - genetics; Adenoma - pathology; Biomarkers, Tumor - genetics; Carcinoma - genetics; Carcinoma - pathology; Cell Transformation, Neoplastic - genetics; Cell Transformation, Neoplastic - pathology; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Mutation; Neoplasms, Cystic, Mucinous, and Serous - genetics; Neoplasms, Cystic, Mucinous, and Serous - pathology; Ovarian Neoplasms - genetics; Ovarian Neoplasms - pathology; Phenotype; Proto-Oncogene Proteins p21(ras) - genetics; Research Paper: Pathology; mucinous borderline tumor (MBT); mucinous carcinoma (MC); Pathology Section; anti-epidermal growth factor receptor (anti-EGFR); mucinous adenoma (MA)